Choroidal neovascularization due to AMD
Showing 1 - 25 of >10,000
Impact of Non-Exudative Type 1 MNV on AMD Progression
Recruiting
- Age-Related Macular Degeneration
- Neovascularization, Choroidal
-
Salt Lake City, UtahUniversity of Utah
Nov 15, 2023
Age-Related Macular Degeneration, Choroidal Neovascularization, Genetic Counseling Trial in Salt Lake City (Early disclosure,
Completed
- Age-Related Macular Degeneration
- +2 more
- Early disclosure
- Late disclosure
-
Salt Lake City, UtahUniversity of Utah John A. Moran Eye Center
Aug 10, 2022
Macular Degeneration, Choroidal Neovascularization Trial in 'Aiea, Oak Forest (episcleral brachytherapy)
Recruiting
- Macular Degeneration, Choroidal Neovascularization
- episcleral brachytherapy
-
'Aiea, Hawaii
- +1 more
Feb 11, 2022
Pathological Myopic Choroidal Neovascularization Trial in BeiJing (601, Ranibizumab)
Recruiting
- Pathological Myopic Choroidal Neovascularization
-
BeiJing, ChinaPeking Union Medical College Hospital
Jun 4, 2021
Neovascular (Wet) Age-related Macular Degeneration Trial (Aflibercept(BAY86-5321, Eylea))
Not yet recruiting
- Neovascular (Wet) Age-related Macular Degeneration
- Aflibercept(BAY86-5321, Eylea)
- (no location specified)
Jul 22, 2022
Choroidal Neovascularization, Wet Macular Degeneration Trial in United States (ICON-1, aflibercept)
Terminated
- Choroidal Neovascularization
- Wet Macular Degeneration
- ICON-1
- aflibercept
-
Beverly Hills, California
- +7 more
Mar 21, 2021
Age-related Macular Degeneration, Neovascular Age-related Macular Degeneration, Wet Macular Degeneration Trial in Australia
Completed
- Age-related Macular Degeneration
- +2 more
- bevacizumab
- ranibizumab
-
Hurstville, New South Wales, Australia
- +8 more
May 7, 2021
Study of Dark Adaptation in Age-Related Macular Degeneration
Recruiting
- Age-Related Macular Degeneration
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Aug 24, 2022
Age-related Macular Degeneration, Neovascular Age-related Macular Degeneration, Wet Macular Degeneration Trial in United States
Completed
- Age-related Macular Degeneration
- +2 more
- bevacizumab
- ranibizumab
-
Tucson, Arizona
- +49 more
Feb 15, 2022
Age-related Macular Degeneration Trial in Coimbra (Blood draw and urine collection)
Completed
- Age-related Macular Degeneration
- Blood draw and urine collection
-
Coimbra, PortugalAIBILI
Jan 6, 2023
Quantitative Metamorphopsia- Measurements in Patients With mCNV
Completed
- Metamorphopsia
- App
-
Binningen, Baselland, SwitzerlandVista Klinik
Dec 8, 2021
Exudative Macular Degeneration, Wet Age-related Macular Degeneration Trial in Iowa City (Doxycycline Hyclate, Placebo)
Recruiting
- Exudative Macular Degeneration
- Wet Age-related Macular Degeneration
- Doxycycline Hyclate
- Placebo
-
Iowa City, IowaUniversity of Iowa Hospitals & Clinics Department of Ophthalmolo
Apr 5, 2022
s in Wet AMD in Active Smokers
Completed
- Wet Age-related Macular Degeneration
- Medical Data extraction
-
Brussels, BelgiumCHU Brugmann
Mar 7, 2022
Neovascular Age-Related Macular Degeneration Trial in China (Brolucizumab 6mg, Aflibercept 2 mg)
Recruiting
- Neovascular Age-Related Macular Degeneration
- Brolucizumab 6mg
- Aflibercept 2 mg
-
Guangzhou, Guangdong, China
- +30 more
Jan 20, 2023
Outcomes of Tolerating Subretinal Fluid in Type 1 MNV and PCV
Recruiting
- Polypoidal Choroidal Vasculopathy
- +2 more
- Intravitreal aflibercept injection
-
Seoul, Korea, Republic ofJae Hui Kim
Dec 20, 2022
Neovascular Age-related Macular Degeneration, Diabetic Macular Edema, Retinal Vein Occlusion Trial in Shanghai (BD311)
Recruiting
- Neovascular Age-related Macular Degeneration
- +2 more
- BD311
-
Shanghai, Shanghai, ChinaEye & ENT Hospital of Fudan University
Aug 22, 2022
Imaging of the Angiofibrotic Switch in Neovascular AMD
Unknown status
- Age-related Macular Degeneration
- Choroidal Neovascularization
- Best-corrected Visual acuity testing (BCVA)
- +7 more
-
Vienna, AustriaMedical University of Vienna
Feb 19, 2020
Geographic Atrophy, Age Related Macular Degeneration, AMD Trial in Somerville (ALK-001 oral capsule, Placebo oral capsule)
Active, not recruiting
- Geographic Atrophy
- +3 more
- ALK-001 oral capsule
- Placebo oral capsule
-
Somerville, MassachusettsCoordinating Center
Feb 15, 2022
AMD, Age-related Macular Degeneration, Choroidal Neovascularisation Trial in Poitiers (Resvega, Trans-Resveratrol, )
Terminated
- AMD
- +2 more
- Resvega
- +2 more
-
Poitiers, FranceCHU de Poitiers - Ophtalmology
May 29, 2020
Choroidal Neovascularization Trial in United States (Faricimab, Ranibizumab, Sham Procedure)
Non-invasive Optical Angiography in Age-related Macular
Recruiting
- Age Related Macular Degeneration
- Non-invasive OCT based optical angiography
- +3 more
-
Vienna, AustriaMedical University of Vienna
Jan 13, 2023
Pachychoroid Neovasculopathy Trial (Three monthly injections of intravitreal aflibercept)
Not yet recruiting
- Pachychoroid Neovasculopathy
- Three monthly injections of intravitreal aflibercept
- (no location specified)
Dec 14, 2022
Non Exudative AMD Imaged With SS-OCT- Extension
Recruiting
- Dry Macular Degeneration
- SS-OCT imaging
-
Los Angeles, California
- +4 more
Mar 8, 2022
Choroidal Ischemia, Vitelliform Macular Dystrophy, Age-related Macular Degeneration Trial in New York (drug, other, diagnostic
Recruiting
- Choroidal Ischemia
- +4 more
- Sildenafil
- +3 more
-
New York, New YorkColumbia University Medical Center, Edward Harkness Eye Institut
May 2, 2022
Optical Coherence Tomography Angiography Criteria Of The
Not yet recruiting
- Choroidal Neovascular Membrane In Wet Age Related Macular Degeneration And In Pathological Myopia
- Optical coherence tomography angiography
- (no location specified)
Sep 27, 2022